LORI GIBSON: Open Payments
NPI 1235444209 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 47 payments from 21 companies in 2025. Trend: 2023 $818 · 2024 $671 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Lilly USA, LLC | 5 | $109 |
| ABBVIE INC. | 5 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Verona Pharma, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Amgen Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $36 |
Products named: Kerendia, JARDIANCE, MOUNJARO, Auvelity, Ohtuvayre, CAPLYTA, QULIPTA, Ozempic.
Industry payments across IN — which companies pay providers there.
